References
- Institute of Medicine. Preterm birth: Causes, consequences, and prevention. Washington, DC: National Academies Press, 2006
- McLaurin KK, Hall CB, Jackson EA, et al. Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life. Pediatrics 2009;123:653-9
- Engle WA, Tomashek KM, Wallman C. “Late-preterm” infants: a population at risk. Pediatrics 2007;120:1390-401
- Boyce TG, Mellen BG, Mitchel EF, Jr et al. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000;137:865-70
- Coffman S. Late preterm infants and risk for RSV. MCN Am J Matern Child Nurs 2009;34:378-84; quiz 85-6
- Forbes ML, Hall CB, Jackson A, et al. Comparative costs of hospitalisation among infants at high risk for respiratory syncytial virus lower respiratory tract infection during the first year of life. J Med Econ 2010;13:136-41
- International Classification of Diseases, 9th Revision, Clinical Modification, 4th edn. Practice Management Information Corporation, 2006
- HIPAA privacy rule and public health. Guidance from CDC and the U.S. Department of Health and Human Services. MMWR Morb Mortal Wkly Rep 2003;52(Suppl):1-17, 9-20
- Department of Health and Human Services. Code of Federal Regulations. Title 45 – Public Welfare. Part 46 Protection of Human Subjects. Subpart A – Basic HHS Policy for Protection of Human Research Subjects. Available at: http://ohsr.od.nih.gov/guidelines/45cfr46.html. [Accessed January 25, 2011]
- Imai K, van Dyk DA. Causal inference with general treatment regimes. J Am Stat Assoc 2004;99:854-66
- Imbens G. The role of the propensity score in estimating dose-response functions. Biometrika 2000;87:706-10
- Imbens GW. Nonparametric estimation of average treatment effects under exogeneity: a review. Rev Econ Stat 2004;86:4-29
- Greenough A, Alexander J, Burgess S, et al. Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection. Arch Dis Child 2004;89:673-8
- Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child 2001;85:463-8
- Paramore LC, Ciuryla V, Ciesla G, et al. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 2004;22:275-84
- Sampalis JS. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr 2003;143:S150-6
- Hall CB. Respiratory syncytial virus. In Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases, 4th edn. Philadelphia, PA: WB Saunders, 1998 2084-110
- Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2006. Natl Vital Stat Rep 2009;57:1-104